Consolidated and Combined Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Predecessor
Dec. 31, 2011
Predecessor
Cash Flows from Operating Activities:      
Net loss $ (2,636)    
Net loss   (1,534) (3,060)
Adjustments to reconcile net loss to net cash provided by operating activities      
Depreciation and amortization 5,107 4,161 4,783
Gain on sale of investment properties   (1,519)  
Loss on sale of property under development 2 228  
Amortization of lease inducement and above market leases 141 70 29
Change in fair value of derivatives, net (246) (122) 325
Provision for bad debts 30 320 523
Impairment losses   937 1,437
Non-cash compensation 433    
Amortization and write-off of deferred financing costs 510 268 255
(Increase) decrease in      
Tenant receivables (184) 33 (312)
Deferred costs (163) (153) (194)
Other assets (1,749) 268 (590)
Increase (decrease) in      
Accounts payable to related parties (1,530) 255 (124)
Accounts payable 34 204 (594)
Accrued expenses and other liabilities 1,256 (56) 500
Total Adjustments 3,641 4,894 6,038
Net cash provided by operating activities 1,005 3,360 2,978
Cash Flows from Investing Activities:      
Proceeds from sale of investment properties 448 14,525  
Capital expenditures for acquisition of investment properties (125,728) (845) (52)
Lease inducement (1,000)    
Net cash (used in)/provided by investing activities (126,280) 13,680 (52)
Cash Flows from Financing Activities:      
Proceeds from sale of common shares 244,934    
Offering costs (19,014)    
Formation transactions (354)    
Proceeds from credit facility borrowings 52,350    
Payments on credit facility borrowings (52,350)    
Proceeds from issuance of debt 162 45 695
Debt issuance costs (1,428) (270) (52)
Payments on notes payable (41,832) (14,149) (2,639)
Dividends paid (2,654)    
Distributions to members and partners (211) (1,671) (1,525)
Contributions to noncontrolling interest     24
Distributions to noncontrolling interest (464) (313) (261)
Net cash provided by/(used in) financing activities 179,139 (16,358) (3,758)
Net increase (decrease) in cash and cash equivalents 53,864 682 (832)
Cash and cash equivalents, beginning of year 2,614 1,932 2,764
Cash and cash equivalents, end of period 56,478 2,614 1,932
Supplemental disclosure of cash flow information interest paid during the year 3,942 5,126 5,050
Supplemental disclosure of noncash activity -- accrued dividends payable 5,681    
Supplemental disclosure of noncash activity -- contributions to noncontrolling interest $ 12,095